TABLE 2

Univariate and Multivariate Analysis of Predictors of High GRPR Expression

Univariate analysisMultivariate analysis
CharacteristicCategoryNo. of patientsPOdds ratioPOdds ratio
Age (y)<4085<0.00011Nonsignificant (not retained)
41–50287<0.00012.897 (1.742–4.816)
>501,060<0.00012.851 (1.818–4.472)
HistologyIDC1,2210.03891Not retained
ILC1610.09101.427 (0.945–2.155)
Other430.04792.586 (1.009–6.628)
Pathologic size (mm)≥20471<0.00011Not retained
<209611.699 [1.324 ; 2.180]
SBR gradeGrade III397<0.000110.00051
Grade II661<0.00014.637 (3.495–6.154)0.00231.831 (1.242–2.699)
Grade I358<0.00017.965 (5.395–11.761)0.00022.617 (1.591–4.303)
Ki-67≥20%317<0.000110.01961
<20%1,1154.869 (3.716–6.378)1.584 (1.076–2.330)
Lymph node statusN+4720.000610.03501
N08480.02891.329 (1.030–1.715)0.31171.173 (0.861–1.597)
Missing1120.00033.082 (1.672–5.681)0.01032.636 (1.257–5.526)
ER0%150<0.00011<0.00011
≥1%1,28236.394 (21.772–60.837)11.998 (5.980–24.075)
PR0%266<0.000110.04291
≥1%1,1668.259 (6.167–11.061)1.652 (1.016–2.686)
AR<10%184<0.000110.00271
≥10%1,2487.509 (5.389–10.462)2.011 (1.275–3.173)
HER2 overexpressionYes1460.000210.00381
No1,2861.989 (1.387–2.852)0.461 (0.273–0.779)
  • IDC = invasive ductal carcinoma; ILC = invasive lobular carcinoma.

  • Statistical analysis based on Cox model; P < 0.05 was considered significant. Data in parentheses are 95% CIs.